iBiomatics

Website Links

Description

With so many challenges facing the life sciences industry – pricing pressures, pipeline pressures, impending patent expirations, the soaring cost of developing new drugs – the strength of these companies as well as the intellectual property they need to improve the health of the public is being threatened. While the focus seems to be shifting to personalized medicine – the right drug for the right patient – personalized drugs will most likely mandate significant changes to life sciences companies' business practices. How can drug companies remain profitable so they can continue to deliver the best drugs to the public?

Companies nearby